PLoS ONE (Jan 2010)

Mutations in SCG10 are not involved in Hirschsprung disease.

  • Maria M M Alves,
  • Jan Osinga,
  • Joke B G M Verheij,
  • Marco Metzger,
  • Bart J L Eggen,
  • Robert M W Hofstra

DOI
https://doi.org/10.1371/journal.pone.0015144
Journal volume & issue
Vol. 5, no. 12
p. e15144

Abstract

Read online

Hirschsprung disease (HSCR) is a congenital malformation characterized by the absence of enteric neurons in the distal part of the colon. Several genes have been implicated in the development of this disease that together account for 20% of all cases, implying that other genes are involved. Since HSCR is frequently associated with other congenital malformations, the functional characterization of the proteins encoded by the genes involved in these syndromes can provide insights into the protein-network involved in HSCR development. Recently, we found that KBP, encoded by the gene involved in a HSCR- associated syndrome called Goldberg-Shprintzen syndrome, interacts with SCG10, a stathmin-like protein. To determine if SCG10 is involved in the etiology of HSCR, we determined SCG10 expression levels during development and screened 85 HSCR patients for SCG10 mutations. We showed that SCG10 expression increases during development but no germline mutation was found in any of these patients. In conclusion, this study shows that SCG10 is not directly implicated in HSCR development. However, an indirect involvement of SCG10 cannot be ruled out as this can be due to a secondary effect caused by its direct interactors.